Latham & Watkins advises Ardian in the sale of its majority stake of Kersia to IK Investment Partners

Exclusive negotiations between a world-leading private investment house and IK Investment Partners.

12/10/2020

Ardian, a world-leading private investment house, has entered into exclusive negotiations with IK Investment Partners to sell its majority stake in Kersia, a global leader in biosecurity and food safety.
Kersia was formed as a new company in 2016 after Hypred acquired Antigerm, LCB Food Safety, G3, Kilco, Choisy Laboratories and Holchem, with each acquisition carefully chosen for their complementary technologies, leading market positions, and business expertise. The Company has tripled in size in less than four years. Over the last four years, Kersia has grown to become a global leader in biosecurity and food safety. The Company, which has revenues in excess of €300 million, now operates in more than 120 countries with a workforce of over 1,500 people. 

Latham advised Ardian on this transaction with corporate a team in Paris led by partner Gaëtan Gianasso, assisted by Timothée Brunello, François Blanchet, Aymerick Fradin and Christos Ierna. Carla-Sophie Imperadeiro, counsel, advised on the financing aspects, Mathilde Saltiel, counsel, assisted by Juliette Hua, advised on the competition aspects. 

 
 

Avertissement : Nous vous remercions de l’intérêt que vous portez à Latham & Watkins. Si vous souhaitez nous confier un dossier mais que vous n'êtes pas encore client du cabinet, merci de ne nous transmettre aucune information confidentielle. Nous ne pouvons pas accepter un dossier avant de nous être assurés que nous sommes en mesure de vous assister et d’avoir trouvé un accord avec vous sur les termes et conditions de notre intervention. Dans la mesure où nous n’aurons pas de relation avocat-client avec vous auparavant, nous n’aurons aucune obligation de confidentialité à l’égard des informations que vous nous auriez transmises. Merci de votre compréhension.